NCT04458922 2026-03-17Testing Atezolizumab in People 2-17 Years Old With Clear Cell Sarcoma or Advanced ChondrosarcomaNational Cancer Institute (NCI)Phase 2 Active not recruiting27 enrolled 16 charts